About: Chandra Belani

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Chandra Belani Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) researcher (en) 연구원 (ko) ricercatore (it) গবেষক (bn) 研究者 (ja) chercheur (fr) wetenschapper (nl) дослідник (uk) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) researcher (en-ca) researcher (en-gb) researcher (en-us) investigador (ca) investigador (gl) investigador (ast) investigador (pt) investigador/a (es)
rdfs:label	Chandra Belani (en) Chandra Belani (es) Chandra Belani (it) Chandra Belani (nl) Chandra Belani (sl) Chandra Belani (ast) Chandra P. Belani (cs)
skos:prefLabel	Chandra Belani (en) Chandra Belani (es) Chandra Belani (it) Chandra Belani (nl) Chandra Belani (sl) Chandra Belani (ast) Chandra P. Belani (cs)
name	Chandra Belani (en) Chandra Belani (es) Chandra Belani (it) Chandra Belani (nl) Chandra Belani (sl) Chandra Belani (ast) Chandra P. Belani (cs)
instance of	wds:Q40073451-78E414A1-9E9E-43C2-A507-F4EAF57099D8
NL CR AUT ID	wds:Q40073451-91FF1636-2C66-4353-99ED-37E5C8AFD3D8
instance of	Homo sapiens
NL CR AUT ID	xx0058996
Nationale Thesaurus voor Auteursnamen ID	wds:Q40073451-C29DEAEB-C3E2-4AB4-B13F-68060FBC03FF
occupation	wds:Q40073451-E726649A-4285-438B-8F3B-A128C0C1634A
employer	wds:Q40073451-E64A6499-CB41-455B-8B43-262412C89E77
VIAF ID	wds:Q40073451-74AC9DE8-F898-4C35-BA26-2AE9A7E9F311
Library of Congress authority ID	wds:Q40073451-6DB9C665-BF03-47BC-8154-E2BA4E3E172E
PLWABN ID	wds:Q40073451-9AD17646-375A-42DA-AB63-DF1205C5D005
family name	wds:Q40073451-F445C377-BC0B-4AE5-8993-E9E4187B3D4E
WorldCat Identities ID (superseded)	wds:Q40073451-D1DDD7DA-8CD5-4D1B-8A1B-599171C2841C
Nationale Thesaurus voor Auteursnamen ID	http://data.bibliotheken.nl/id/thes/p166928011
VIAF ID	http://viaf.org/viaf/315223752
Library of Congress authority ID	http://id.loc.gov/authorities/names/n2011185303
Nationale Thesaurus voor Auteursnamen ID	166928011
occupation	researcher
employer	Penn State Milton S. Hershey Medical Center
VIAF ID	315223752
Library of Congress authority ID	n2011185303
PLWABN ID	9810658391605606
family name	Belani
WorldCat Identities ID (superseded)	lccn-n2011185303
Springer Nature person ID	wds:Q40073451-8218CEC7-DB77-42CC-9169-962CA16B0AA3
ORCID iD	wds:Q40073451-AE035266-9C51-4D58-BA5A-BFC5E9A4F7A5
Dimensions author ID	wds:Q40073451-0EB88E14-3973-41D1-9EB3-B19A086AC98E
ORCID iD	https://orcid.org/0000-0001-5049-5329
Springer Nature person ID	01262013101.85
ORCID iD	0000-0001-5049-5329
Dimensions author ID	01262013101.85
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q40073451
is author of	Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-c Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage Paclitaxel and carboplatin in metastatic non-small cell lung cancer: preliminary results of a phase I study. Vorinostat in solid and hematologic malignancies Carboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study Single agent maintenance therapy for advanced stage non-small cell lung cancer: a meta-analysis Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancer Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: a controlled, randomized, open-label phase II trial A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale. Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer Multicenter, Randomized Trial for Stage IIIB or IV Non–Small-Cell Lung Cancer Using Weekly Paclitaxel and Carboplatin Followed by Maintenance Weekly Paclitaxel or Observation Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers A Phase I Study of 17-Allylamino-17-Demethoxygeldanamycin Combined with Paclitaxel in Patients with Advanced Solid Malignancies Evaluation of Plasma Insulin-like Growth Factor Binding Protein 2 and Her-2 Extracellular Domain as Biomarkers for 17-Allylamino-17-Demethoxygeldanamycin Treatment of Adult Patients with Advanced Solid Tumors Randomized, Phase III Study of Weekly Paclitaxel in Combination With Carboplatin Versus Standard Every-3-Weeks Administration of Carboplatin and Paclitaxel for Patients With Previously Untreated Advanced Non–Small-Cell Lung Cancer Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594. Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Chemotherapy for advanced non-small cell lung cancer: past, present, and future

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software